The SAFE note is the most commonly misunderstood instrument in early-stage GCC fundraising. Founders sign them because they are fast and founder-friendly by reputation. What they are less clear on is what they are actually agreeing to, how the economics play out at conversion, and what happens when the terms are not well-drafted for a regional context.

This post covers how SAFE notes work in practice, the terms that matter and why, and where the instrument fits — and does not fit — in a GCC raise. It sits alongside the broader guide to raising capital in the GCC, which covers the full fundraising process from investor research through to close.

What a SAFE note actually is

SAFE stands for Simple Agreement for Future Equity. It was developed by Y Combinator in 2013 as a simpler alternative to convertible notes for early-stage fundraising. Unlike a convertible note, a SAFE is not debt. It carries no interest rate, no maturity date, and no obligation to repay. In exchange for capital today, the investor receives the right to convert into equity at a future priced round, on terms determined by whichever conversion triggers apply.

That simplicity is real. A well-drafted SAFE can be negotiated and signed in days rather than weeks. There is no interest accruing. There is no cliff where the company needs to repay or refinance if a priced round has not closed by a certain date. For a founder raising a pre-seed round quickly, these are genuine advantages.

The simplicity is also partial. A SAFE defers complexity rather than eliminating it. The economics that a convertible note would surface upfront — what is this investment worth at conversion, what protections does the investor get — are all still present in a SAFE. They just resolve later, at the priced round, when the cap table is already partially committed and the negotiating dynamic has shifted.

The two terms that determine most of the economics

Every SAFE has a conversion mechanism. The two most common are a valuation cap, a discount, or both. Understanding how they interact is the foundation of any sensible SAFE negotiation.

Valuation cap. The cap sets the maximum valuation at which the SAFE converts into equity. If a SAFE has a $5M cap and the company raises its priced Series A at a $15M pre-money valuation, the SAFE investor converts as if the company were valued at $5M — getting three times as many shares as a Series A investor paying the same cash amount. The cap protects early investors from being diluted by the company's own progress between the SAFE and the priced round.

From the founder's perspective, the cap is the most consequential term to negotiate. A cap that is too low, relative to where the company actually lands at Series A, can produce significant dilution that was not anticipated at the time of signing. A cap set at $5M for a company that raises a Series A at $20M gives SAFE investors a four-to-one advantage at conversion. Multiply that across several SAFE holders and the dilution picture changes materially.

Discount. A discount gives the SAFE investor the right to convert at a percentage below the priced round price, regardless of valuation. A 20% discount means that if the Series A price per share is $1.00, the SAFE investor converts at $0.80. The discount rewards early investors for taking on timing risk, without anchoring the conversion to a specific valuation.

When both a cap and a discount are present, the investor typically gets whichever is more favourable at conversion. A SAFE with a $5M cap and a 20% discount converts using the cap if the priced round valuation makes the cap more advantageous, and using the discount if not. That optionality has value, and it is worth understanding before you agree to both terms in a single instrument.

MFN clause. Most-Favoured-Nation provisions are common in uncapped SAFEs. They give the SAFE investor the right to adopt the terms of any future SAFE that is more favourable than theirs. An MFN clause on an uncapped SAFE effectively means that if you later issue a SAFE with a cap, the earlier uncapped investor can elect to add that cap to their instrument. This can create complexity when you are issuing SAFEs across multiple closes with different terms.

How SAFEs convert — and where founders get surprised

The conversion mechanics matter at two points: at the priced round, and at an exit or liquidation event that occurs before a priced round closes.

At a priced round, SAFEs convert automatically (in most structures) into the same class of shares issued in that round, at the price determined by the cap or discount. The conversion is typically into the preferred share class being issued, with the same rights and preferences as the new investors — unless the SAFE specifies otherwise.

The mechanics around pro-rata rights in SAFEs deserve particular attention. A SAFE with pro-rata rights gives the investor the right to participate in the priced round up to their ownership percentage at conversion. In a competitive priced round with limited allocation, pro-rata rights from SAFE holders can constrain how much new capital you can raise from incoming investors. This is manageable when there is one or two SAFE investors. It becomes more complicated when you have a cap table with five or six SAFE holders all holding pro-rata rights into a single round.

At an exit before a priced round, the outcome depends on the SAFE terms. Most SAFEs include a liquidity provision that gives investors either a return of their investment or conversion into common shares at the cap valuation, whichever is more favourable. In an early acquisition where the exit price is below or close to the SAFE cap, this provision can produce unexpected outcomes for founders and common shareholders.

SAFE notes in ADGM and DIFC

The SAFE note originated in the US Delaware corporate environment. Applying it in the UAE requires attention to which jurisdiction your company is incorporated in and how the instrument is adapted for that context.

Both ADGM and DIFC are common law jurisdictions, which means the general contractual principles underlying a US SAFE translate reasonably well. The key adaptation is in how the instrument is documented relative to the company's articles of association and shareholder agreement. A SAFE that is not properly referenced in the constitutional documents of an ADGM or DIFC company can create ambiguity about the investor's rights at conversion, particularly in relation to anti-dilution provisions, voting rights, and information rights that attach to the share class they are converting into.

In practice, most investors operating in the ADGM and DIFC ecosystems are familiar with SAFE-style instruments and have their own preferred templates. Reviewing those templates against your existing corporate documents before signing matters. An investor template drafted for a US Delaware company may include provisions — around tax treatment, securities law compliance, or dispute resolution — that need to be adapted for an ADGM or DIFC entity.

One area where jurisdiction-specific advice is genuinely important: the treatment of SAFEs under UAE federal law. While ADGM and DIFC operate as common law zones with their own regulatory frameworks, companies incorporated outside those zones face a different legal environment where convertible instruments are not always treated the same way. If your company is incorporated onshore in the UAE rather than in ADGM or DIFC, take specific advice on how the instrument is characterised before issuing it.

For Saudi-based founders, the SAFE presents an additional structural problem. Islamic finance principles prohibit interest-bearing arrangements, and standard convertible instruments sit uncomfortably within that framework. The instrument developed for that context is the OQAL Note, a standardised Sharia-compliant financing mechanism built around a Qard Hassan structure that converts into equity at a priced round. If your company is incorporated onshore in Saudi Arabia or your investor base requires Sharia-compliant documentation, the OQAL Note is the relevant instrument rather than a standard SAFE. For a full breakdown of how it works and when to use it, read The OQAL Note: Saudi Arabia's Sharia-Compliant Alternative to the SAFE.

When a SAFE makes sense — and when it doesn't

The SAFE note is well-suited to a specific situation: a founder raising a relatively small amount of pre-seed capital quickly, from investors who understand the instrument, where both sides want to avoid the time and cost of a full priced round.

It works less well in a few situations that are more common in the GCC than founders typically anticipate.

When you are raising from investors who are unfamiliar with the instrument. Family offices, angel investors, and some government-backed vehicles in the GCC are less familiar with SAFE notes than US-trained investors. Signing a SAFE with an investor who does not fully understand how conversion works creates problems later — particularly around pro-rata rights and liquidation outcomes. If your investor pool includes parties who are not SAFE-literate, a simpler convertible note with explicit repayment terms may actually create fewer disputes down the line.

When the round is large enough to justify a priced equity round. A SAFE makes sense for a $250K to $500K pre-seed raise. Once you are raising $1M or more from institutional investors, the time saved on a SAFE relative to a priced round is smaller, and the deferred complexity around conversion and pro-rata rights is larger. Many GCC institutional investors at that round size will prefer a priced equity round where the economics are clear upfront.

When you already have multiple SAFEs on your cap table. Stacking SAFEs across successive pre-seed closes without converting creates an increasingly complex cap table that will need to be unwound at the priced round. Each SAFE has its own cap, discount, and pro-rata terms. Founders who have issued five or six SAFEs to different investors over eighteen months often find the conversion calculation at Series A to be significantly more complicated than they expected. At some point, a priced round is cleaner.

What to negotiate before you sign

Most founders treat a SAFE as non-negotiable because it has a reputation for being standard. The YC template is a starting point, not a ceiling.

The terms worth pushing on before signing:

The valuation cap should reflect where you realistically expect to be at Series A, with enough headroom that you are not handing back a disproportionate ownership stake if the company performs well. If you are raising at a $4M cap and you expect to raise your Series A at $15M to $20M, you are building in significant dilution for early investors at the expense of founders and later investors. That is not inherently wrong — early investors take real risk — but it should be a deliberate decision, not a default.

Pro-rata rights should be considered carefully before being granted automatically. If you are issuing SAFEs to multiple investors and all of them hold pro-rata, your flexibility to structure the priced round is constrained from the start. Pro-rata rights are appropriate for lead investors committing meaningful capital. They are less appropriate for every angel investor writing a $25K cheque.

Information rights in SAFEs are sometimes overlooked because they seem standard. Before you agree to provide quarterly financials, board observer rights, or annual audited accounts to every SAFE holder, consider how many investors you are likely to have on your cap table before the priced round. Each information right is an obligation that scales with the number of investors.

Dispute resolution. If your company is incorporated in ADGM or DIFC, make sure the dispute resolution clause in the SAFE is consistent with your corporate jurisdiction. A SAFE that specifies US courts or arbitration under US rules creates unnecessary complexity for a GCC-incorporated entity.

Work with Dopamine on your convertible instrument

If you are negotiating a SAFE or considering whether it is the right instrument for your raise, the Term Sheet Strategy session covers convertible instruments alongside priced round term sheets in detail. If you want to understand how a SAFE converts into your cap table and what that means for dilution across your next two rounds, the Cap Table and Liquidity session works through that directly.

FAQ

Is a SAFE note the same as a convertible note?No. A convertible note is debt: it carries an interest rate and a maturity date, and the company is obligated to repay it if a conversion event does not occur. A SAFE is not debt. It carries no interest, no maturity date, and no repayment obligation. Both instruments convert into equity at a priced round, but the legal nature of the instrument and the risk profile for both sides are different.

Do SAFE notes work in ADGM and DIFC?Yes, with adaptation. Both ADGM and DIFC are common law jurisdictions and the general contractual principles underlying a SAFE translate well. The instrument needs to be properly referenced in the company's constitutional documents and reviewed for any provisions that are specific to a US Delaware entity. For companies incorporated onshore in the UAE outside ADGM and DIFC, take specific advice before issuing a SAFE.

What is a reasonable valuation cap for a GCC pre-seed SAFE?The cap should be set relative to where you realistically expect to raise your priced round, with enough margin to make the early investor's economics sensible without producing disproportionate dilution at conversion. In the GCC, where seed valuations typically sit between $5M and $10M pre-money, a pre-seed SAFE cap in the $3M to $6M range is broadly defensible for most sectors. The right number depends on your traction, team, and sector. Read our breakdown of GCC pre-seed and seed valuation ranges for the fuller picture.

What happens to a SAFE if the company is acquired before a priced round?Most SAFEs include a change-of-control provision that gives investors the choice between receiving a return of their capital or converting into common shares at the cap valuation. If the acquisition price is below the cap, investors will usually take their cash back. If the acquisition price implies a per-share value above the cap, they will convert. The specific mechanics depend on the SAFE terms, which is why reviewing them carefully before signing matters.

How many SAFEs should I issue before doing a priced round?Two, as a general rule. One at pre-seed, a second at seed if you need it, and then a priced equity round. SAFEs exist because valuing a company at the earliest stages is genuinely difficult, and deferring that conversation makes sense when there is not enough data to support a priced round. That justification weakens as the business matures. Issuing a third or fourth SAFE is usually a sign that the valuation conversation is being avoided rather than that the instrument is still the right tool. Beyond two caps, the conversion complexity at your priced round compounds quickly, and incoming Series A investors will want to understand a cap table that is already partially committed before they write their cheque. Two SAFEs and then equity is a structure that works cleanly. More than that starts working against you.

Should every pre-seed investor get pro-rata rights?No. Pro-rata rights are appropriate for lead investors committing meaningful capital who need to maintain their ownership percentage in future rounds. Granting pro-rata rights to every angel investor in a pre-seed round creates obligations that constrain your flexibility at Series A. A common approach is to grant pro-rata to investors above a threshold cheque size and exclude it below.

Related reading

‍